Fast-Acting Nasal Spray for Migraine Snags FDA Approval
The FDA approved intranasal zavegepant (Zavzpret) for acute migraine, making it the first calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray with this indication, drugmaker Pfizer announced on Friday. Zavegepant is indicated for the treatment of migraine with or without aura, and is not indicated for preventing migraine. The pathophysiology of migraines is related to […]